Evolution of the Average Target: Tenax Therapeutics, Inc.

Evolution of the Target Price: Tenax Therapeutics, Inc.

Changes in Analyst Recommendations: Tenax Therapeutics, Inc.

c895d401725b2db16b2bdf24bda5c675._xfEb4-spEFKLagvmE3CCnDels4ZTqgpFnQ4FJ5oVLs.vU-0W-HjlAYYXs9MxzT1aEmo-6NPJssYIg5ecNQNNY6wWKNYwvjJBh9s4Q~94656a63fa2be3a36f19fdf69400301a

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+578.68%
+17.44%
+18.9%
+4.71%
+19.45%
+42.8%
+17.43%
-1.89%
-0.35%
-3.69%
Average +69.35%
Weighted average by Cap. +16.04%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
1.780USD
Average target price
12.56USD
Spread / Average Target
+605.37%
High Price Target
36.00USD
Spread / Highest target
+1,922.47%
Low Price Target
4.000USD
Spread / Lowest Target
+124.72%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
  1. Stock Market
  2. Stocks
  3. TENX Stock
  4. Consensus Tenax Therapeutics, Inc.